Patient P-01571

Synthetic patientNBL-101 · Day 104 · 25–34 · M · baseline S13Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Stable

Discontinuation risk

23%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S13
Day 80 SC-12 recommended — Supportive Compound SC-12
Day 81 Patient accepted — Started SC-12 in the companion
Day 87 GI symptom burden −12% vs expected — Supportive Compound SC-12
Day 93 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Treatment adherence-6
Nutritional resilience-3

What helped?

Supportive Compound SC-12Day 80
Result: symptom burden −12%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

32.5/100

improving · -4.8 vs previous 14 d

Toxicity

Blood

18.1/100

worsening · +5.9 vs previous 14 d

Sleep quality

Wearable

67.3/100

improving · +4.6 vs previous 14 d

Energy level

Daily log

5.8/10

stable · -0.0 vs previous 14 d

Stress level

Daily log

3.9/10

improving · -0.4 vs previous 14 d

Steps

Wearable

5,969

stable · +109 vs previous 14 d

Adherence

Companion

92 %

stable · +1.8 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 59 from the failing basin, 28 from restoration.

Good elements to keep

Supportive Compound SC-12
intervention · steering +12.5
Butyrate producers intact
hidden · steering +7.5

Main detractors to watch

Poor metabolizer
hidden · steering -12.7
Alcohol
perturbation · steering -10
Simple carbohydrates
perturbation · steering -7.8
Low microbial diversity
hidden · steering -7.7
Alcohol
detractor · GI +5.2 next day
Simple carbohydrates
detractor · GI +4.3 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+5.2detractor · 95%
Simple carbohydrates
+4.3detractor · 95%
Dietary fat load
-0.9no signal · 18%
Insoluble fibre
-0.4no signal · 15%
Spicy / capsaicin
-0.3no signal · 15%
Histamine load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↑25
- WearableResting HR 76 bpm

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 2.8 · butyrate capacity 71/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 52 ms
Sleep: 8.0 h
Steps: 5,998
Resting HR: 74 bpm

Daily log: GI score 33, nutritional resilience 54, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01430	43%	S05	CR-01	improved	54
P-01342	41%	S11	DT-01	improved	48
P-01804	41%	S19	AD-05	improved	61
P-01724	39%	S10	DT-01	improved	63
P-01861	39%	S12	HY-01	improved	47
P-01752	38%	S20	DT-01	improved	50
P-01346	36%	S12	DT-01	improved	52
P-01455	36%	S01	GI-04	improved	61
P-01593	36%	S10	HY-01	improved	56
P-01321	35%	S12	GI-04	improved	53
P-01555	35%	S06	GI-04	improved	56
P-01374	34%	S08	HY-01	improved	49